Annual Accounts Payable
$2.07 M
+$1.62 M+362.33%
31 December 2023
Summary:
Tenax Therapeutics annual accounts payable is currently $2.07 million, with the most recent change of +$1.62 million (+362.33%) on 31 December 2023. During the last 3 years, it has risen by +$1.21 million (+141.17%). TENX annual accounts payable is now at all-time high.TENX Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Accounts Payable
$1.58 M
+$714.40 K+82.14%
30 September 2024
Summary:
Tenax Therapeutics quarterly accounts payable is currently $1.58 million, with the most recent change of +$714.40 thousand (+82.14%) on 30 September 2024. Over the past year, it has dropped by -$489.00 thousand (-23.59%). TENX quarterly accounts payable is now -25.32% below its all-time high of $2.12 million, reached on 31 March 2016.TENX Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TENX Accounts Payable Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | -23.6% |
| 3 y3 years | +141.2% | +84.3% |
| 5 y5 years | +24.8% | -4.6% |
TENX Accounts Payable High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +362.3% | -23.6% | +1075.2% |
| 5 y | 5 years | at high | +362.3% | -23.6% | +1075.2% |
| alltime | all time | at high | >+9999.0% | -25.3% | >+9999.0% |
Tenax Therapeutics Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $1.58 M(+82.1%) |
| June 2024 | - | $869.70 K(-19.5%) |
| Mar 2024 | - | $1.08 M(-47.9%) |
| Dec 2023 | $2.07 M(+362.3%) | $2.07 M(+1437.9%) |
| Sept 2023 | - | $134.80 K(-34.7%) |
| June 2023 | - | $206.50 K(+20.1%) |
| Mar 2023 | - | $172.00 K(-61.6%) |
| Dec 2022 | $448.40 K(-47.8%) | $448.40 K(+69.0%) |
| Sept 2022 | - | $265.40 K(-71.1%) |
| June 2022 | - | $919.40 K(-28.6%) |
| Mar 2022 | - | $1.29 M(+49.7%) |
| Dec 2021 | $859.60 K(+13.4%) | $859.60 K(+10.7%) |
| Sept 2021 | - | $776.20 K(-2.0%) |
| June 2021 | - | $791.90 K(-20.6%) |
| Mar 2021 | - | $997.40 K(+31.6%) |
| Dec 2020 | $757.90 K(-54.4%) | $757.90 K(-28.0%) |
| Sept 2020 | - | $1.05 M(-32.3%) |
| June 2020 | - | $1.55 M(-13.9%) |
| Mar 2020 | - | $1.81 M(+8.7%) |
| Dec 2019 | $1.66 M(+121.5%) | $1.66 M(+636.6%) |
| Sept 2019 | - | $225.50 K(-49.8%) |
| June 2019 | - | $448.80 K(-24.8%) |
| Mar 2019 | - | $596.80 K(-20.4%) |
| Dec 2018 | $749.80 K(+22.5%) | $749.80 K(+91.0%) |
| Sept 2018 | - | $392.50 K(+93.2%) |
| June 2018 | - | $203.20 K(+7.2%) |
| Mar 2018 | - | $189.60 K(-69.0%) |
| Dec 2017 | $611.90 K(-15.9%) | $611.90 K(+5.6%) |
| Sept 2017 | - | $579.40 K(+33.4%) |
| June 2017 | - | $434.20 K(-69.1%) |
| Mar 2017 | - | $1.41 M(+93.1%) |
| Dec 2016 | $727.60 K(-25.2%) | $727.60 K(-47.8%) |
| Sept 2016 | - | $1.39 M(-8.5%) |
| June 2016 | - | $1.52 M(-28.3%) |
| Mar 2016 | - | $2.12 M(+307.0%) |
| Dec 2015 | $972.50 K(-17.9%) | - |
| Oct 2015 | - | $521.20 K(-23.4%) |
| July 2015 | - | $680.70 K(-42.5%) |
| Apr 2015 | $1.18 M(+188.0%) | $1.18 M(+178.4%) |
| Jan 2015 | - | $425.20 K(-74.3%) |
| Oct 2014 | - | $1.65 M(+182.0%) |
| July 2014 | - | $585.90 K(+42.5%) |
| Apr 2014 | $411.10 K(-57.9%) | $411.10 K(-38.5%) |
| Jan 2014 | - | $668.70 K(-27.4%) |
| Oct 2013 | - | $920.80 K(-5.0%) |
| July 2013 | - | $969.60 K(-0.8%) |
| Apr 2013 | $977.20 K(+80.0%) | $977.20 K(+21.0%) |
| Jan 2013 | - | $807.70 K(+68.5%) |
| Oct 2012 | - | $479.30 K(-42.6%) |
| July 2012 | - | $835.10 K(+53.9%) |
| Apr 2012 | $542.80 K | $542.80 K(-16.5%) |
| Jan 2012 | - | $650.40 K(-16.8%) |
| Oct 2011 | - | $781.50 K(-26.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| July 2011 | - | $1.06 M(+19.0%) |
| Apr 2011 | $889.40 K(+78.2%) | $889.40 K(+22.8%) |
| Jan 2011 | - | $724.10 K(-32.7%) |
| Oct 2010 | - | $1.08 M(+18.8%) |
| July 2010 | - | $906.20 K(+81.6%) |
| Apr 2010 | $499.00 K(+155.1%) | $499.00 K(-28.0%) |
| Jan 2010 | - | $693.50 K(+33.2%) |
| Oct 2009 | - | $520.50 K(+100.7%) |
| July 2009 | - | $259.40 K(+32.6%) |
| Apr 2009 | $195.60 K(+206.1%) | $195.60 K(+147.6%) |
| Jan 2009 | - | $79.00 K(+189.4%) |
| Oct 2008 | - | $27.30 K(-73.2%) |
| July 2008 | - | $101.80 K(+59.3%) |
| Apr 2008 | $63.90 K(-83.7%) | $63.90 K(+135.8%) |
| Jan 2008 | - | $27.10 K(-94.2%) |
| Oct 2007 | - | $465.80 K(-6.4%) |
| July 2007 | - | $497.80 K(+27.1%) |
| Apr 2007 | $391.60 K(+158.1%) | $391.60 K(+8.5%) |
| Jan 2007 | - | $360.90 K(+10.4%) |
| Oct 2006 | - | $326.80 K(+13.1%) |
| July 2006 | - | $288.90 K(+90.4%) |
| Apr 2006 | $151.70 K(-43.8%) | $151.70 K(+60.0%) |
| Jan 2006 | - | $94.80 K(+41.3%) |
| Oct 2005 | - | $67.10 K(+35.3%) |
| July 2005 | - | $49.60 K(-81.6%) |
| Apr 2005 | $270.00 K(+13.8%) | $270.00 K(-15.5%) |
| Jan 2005 | - | $319.40 K(+12.5%) |
| Oct 2004 | - | $283.80 K(+38.8%) |
| July 2004 | - | $204.50 K(-13.8%) |
| Apr 2004 | $237.20 K(+1844.3%) | $237.20 K(-18.7%) |
| Jan 2004 | - | $291.70 K(+581.5%) |
| Oct 2003 | - | $42.80 K(-7.6%) |
| July 2003 | - | $46.30 K(+279.5%) |
| Apr 2003 | $12.20 K(-70.4%) | $12.20 K(-83.6%) |
| Jan 2003 | - | $74.20 K(+4.2%) |
| Oct 2002 | - | $71.20 K(+20.7%) |
| July 2002 | - | $59.00 K(+43.2%) |
| Apr 2002 | $41.20 K(-52.8%) | $41.20 K(-70.7%) |
| Jan 2002 | - | $140.70 K(-6.9%) |
| Oct 2001 | - | $151.10 K(+16.7%) |
| July 2001 | - | $129.50 K(+48.3%) |
| Apr 2001 | $87.30 K(-58.7%) | $87.30 K(-38.1%) |
| Jan 2001 | - | $141.00 K(-30.0%) |
| Oct 2000 | - | $201.40 K(-8.3%) |
| July 2000 | - | $219.60 K(+3.8%) |
| Apr 2000 | $211.50 K(-29.5%) | $211.50 K(-29.5%) |
| Jan 2000 | - | $300.00 K(0.0%) |
| Oct 1999 | - | $300.00 K(0.0%) |
| July 1999 | - | $300.00 K |
| Apr 1999 | $300.00 K(-11.6%) | - |
| Apr 1998 | $339.50 K(+5.0%) | - |
| Apr 1997 | $323.40 K(+16.6%) | - |
| Apr 1996 | $277.30 K | - |
FAQ
- What is Tenax Therapeutics annual accounts payable?
- What is the all time high annual accounts payable for Tenax Therapeutics?
- What is Tenax Therapeutics quarterly accounts payable?
- What is the all time high quarterly accounts payable for Tenax Therapeutics?
- What is Tenax Therapeutics quarterly accounts payable year-on-year change?
What is Tenax Therapeutics annual accounts payable?
The current annual accounts payable of TENX is $2.07 M
What is the all time high annual accounts payable for Tenax Therapeutics?
Tenax Therapeutics all-time high annual accounts payable is $2.07 M
What is Tenax Therapeutics quarterly accounts payable?
The current quarterly accounts payable of TENX is $1.58 M
What is the all time high quarterly accounts payable for Tenax Therapeutics?
Tenax Therapeutics all-time high quarterly accounts payable is $2.12 M
What is Tenax Therapeutics quarterly accounts payable year-on-year change?
Over the past year, TENX quarterly accounts payable has changed by -$489.00 K (-23.59%)